PDPK1 and plasma cell myeloma: We previously demonstrated that phosphoinositide-dependent protein kinase-1 (PDPK1) is constitutively and universally active in myeloma cells from the majority of patients, and plays pivotal roles in cell proliferation and cell survival of myeloma cells regardless of the profiles of cytogenetic and genetic abnormalities [29].